Prenatal diagnosis of β-thalassemia in Egypt: Implementing accurate high-tech methods did not reflect much on the outcome

Pediatric Hematology and Oncology

Volumn 25, Issue 6, 2008, Pages 541-548

  Elgawhary, S ^a   Elbaradie Sahar, M Y ^a   Rashad, Wael M ^a   Mosaad, Maha ^a   Abdalla, M A H ^a   Ezzat, G ^a   Wali, Yassar A ^b,d   Elbeshlawy, A ^c  

^a CAIRO UNIVERSITY   (Egypt)

^b SULTAN QABOOS UNIVERSITY   (Oman)

^c CAIRO UNIVERSITY   (Egypt)

^d Sultan Qaboos University College of Medicine and Health Sciences   (Oman)

Author keywords

thalassemia; Egypt; Outcome; Prenatal diagnosis

Indexed keywords

DNA;

AMNION FLUID ANALYSIS; ARTICLE; BETA THALASSEMIA; CHORION VILLUS SAMPLING; CLINICAL ARTICLE; COMPUTER ASSISTED DIAGNOSIS; DIAGNOSTIC ACCURACY; DNA SEQUENCE; FEMALE; FETUS; FIRST TRIMESTER PREGNANCY; HETEROZYGOSITY; HIGH RISK PREGNANCY; HOMOZYGOSITY; HUMAN; INVASIVE PROCEDURE; MUTATIONAL ANALYSIS; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PREGNANCY TERMINATION; PRENATAL DIAGNOSIS; SECOND TRIMESTER PREGNANCY;

BETA-THALASSEMIA; CHORIONIC VILLI SAMPLING; EGYPT; FEMALE; GESTATIONAL AGE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MALE; POLYMERASE CHAIN REACTION; PREGNANCY; PRENATAL DIAGNOSIS; RISK FACTORS; SEQUENCE ANALYSIS, DNA;

EID: 50249091615     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.1080/08880010802313509     Document Type: Article

References (22)

1. Lee GR, Forester J, Lukens J, Paraskovas F, Greer JP, Rodgers GM. The Wintrobe's Clinic Hematology, Vol 1, ed 10. Baltimore: Lippincott, Williams & Wilkins; 1999.
2. Lorey FW, Arnopp J, Cunningham GC. Distribution of hemoglobinopathy variants by ethnicity in multiethnic states. Genet Epidemiol. 1996;13:501-525.
3. Habib Z, Book JA. Thalassemia in the Egyptian population. Hereditas. 1982;95:149-158.
4. Hashem N. Thalassemia syndromes and other hemoglobinopathies: Proceedings of the first international conference, Cairo, Egypt 1978;1:54.
5. El-Beshlawy A, Kaddah N, Hafwz M, Abdel Azim M, Omar N. Genetic study in Egyptian thalassemic patients. Proc EMS ANN Cong Vol. 1994.
6. Vrettou C, Traeger-Synodinos J, Tzetis M, Malamis G, Kanavakis E. Rapid screening of multiple globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. Clin Chem. 2003;49:5769-776.
7. Liao C, Mo QH, Li J, et al. Carrier screening for alpha- and beta-thalassemia in pregnancy: the results of a 11-year prospective program in Guangzhou Maternal and Neonatal Hospital. Prenat Diagn. 2005;25:163-171.
8. Cao A, Rosatelli MC, Monni G, Galanello R. Screening for thalassemia: a model of success. Obstet Gynecol Clin North Am. 2002;29:305-328.
9. Cao A, Rosatelli MC, Galanello R. Control of beta-thalassaemia by carrier screening, genetic counseling and prenatal diagnosis: the Sardinian experience. Ciba Found Symp. 1996;197:137-151.
10. Kanavakis E, Traeger-Synodinos J, Vrettou C, Maragoudaki E, Tzetis M, Kattamis C. Prenatal diagnosis of the thalassemia syndromes by rapid DNA analytical methods. Mol Hum Reprod. 1997;3:523-528.
11. Zhang JZ, Xu XM, Ma WF, Peng ZH. Reverse dot-blot analysis: a rapid prenatal diagnostic approach for thalassemia mutations in Chinese. Chin Sci Bull. 1994;39:1659-1662.
12. Liao C, Xu X, Huang Y. Rapid prenatal diagnosis of 60 cases with beta-thalassemia by reverse dot blot analysis. Zhonghua Fu Chan Ke Za Zhi. 1996;31:348-350.
13. Petrou M, Modell B. Prenatal screening for haemoglobin disorders. Prenat Diagn. 1995;15:1275-1295.
14. Sanguansermsri T, Thanarattanakorn P, Steger HF, et al. Prenatal diagnosis of beta-thalassemia major by high-performance liquid chromatography analysis of hemoglobins in fetal blood samples. Hemoglobin. 2001;25:19-27.
15. Newton CR, Graham A, Heptinstall LE, et al. Analysis of any point mutation in DNA: the amplification refractory mutation analysis system (ARMS). Nucleic Acids Res. 1989;17:2503-2516.
16. Elgawhary S, Aziz M, El-Shafi S, Niazi M, El-Beshlawy A. Study of β-thalassemia mutations using the polymerase chain reaction-amplification refractory mutation system and direct DNA sequencing techniques in a group of Egyptian thalassemia patients. Hemoglobin. 2007;31:63-69.
17. Shams El-Din A, Gaafer M, El-Beshlawy A, Sheba H, Ali H. Molecular characterization of non-transfusion dependent β-thalassemia. Egypt J Lab Med. 1998;10:165-185.
18. El-Beshlawy A, Ragab L, Hussein I, El-Tagui M, Erfan M, Mahmoud S: Genotypes, phenotypes in β-thalassemia and sickle cell anemia in Egypt. JAC. 1995;6:91-96.
19. Lukens JN. The thalassemia and related disorders: quantitative disorders of hemoglobin synthesis. In: Lee GR, Bithell TC, Foerster J, Athens JW, Lukens JN, eds. Wintrobe's Clinical Hematology, ed 9. Philadelphia: Lea & Febiger; 1993.
20. Waye JS, Bory S, Eng B, et al. Spectrum of β-thalassemia mutations in Egypt. Hemoglobin. 1999;23:255-261.
21. Hussein IR, El-Beshlawy A, Tematamy SA, et al. A rapid screening method for the detection of mutations in β-thalassemia patients in Egypt. 5th International Conference on Thalassemia and Haemoglobinopathies, 1993.
22. Wheatherall DJ, Clegg JB. The Thalassemia Syndromes, ed 4. Oxford, UK: Blackwell Science; 2001.